IP Library › Patent Application 18244734
Patent Application
App. No. 18/244,734

COMPOSITION AND THERAPY FOR TREATMENT OF GAG REFLEXES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/244,734
Abstract

The present invention relates to compositions and methods for controlling a gag reflex in a patient.

Claims (14)

1 . A composition for controlling a gag reflex in a patient, the composition comprising sodium chloride and a souring agent in a ratio of 3:1 by volume.

2 . The composition of claim 1 , wherein the composition is a powder form.

3 . The composition of claim 1 , wherein the composition is a liquid form.

4 . The composition of claim 1 , wherein the composition is a dissolving film.

5 . The composition of claim 1 , wherein the composition is an oral disintegrating tablet.

6 . The composition of claim 1 , wherein the souring agent comprises one or more of citric acid, lemon juice, lemon juice powder, lime juice, lime juice powder, amchur, sour plum, sour plum juice, sour plum juice powder, sumac, tamarind, tamarind powder, vinegar, vinegar powder, umeboshi vinegar, umeboshi vinegar powder, verjuice, verjuice powder.

7 . The composition of claim 4 , wherein the dissolving film comprises one or more excipients selected from the group consisting of strip-forming polymers, plasticizers, sweetening agents, saliva stimulating agents, flavoring agents, coloring agents, stabilizing agents, and thickening agents.

8 . A method for controlling a gag reflex in a patient, the method comprising:

providing a composition consisting essentially of sodium chloride and a souring agent in a ratio of 3:1 by volume; and

administering a therapeutic amount of the composition to the patient by contacting a top surface of the patient's tongue with the therapeutic amount of the composition.

9 . The method of claim 8 , comprising a step for delaying an oral procedure by a delay of less than 20 seconds after administering the therapeutic amount of the composition to the patient.

10 . The method of claim 8 , comprising a step for commencing an oral procedure within 12 hours after administering the therapeutic amount of the composition to the patient.

11 . The method of claim 8 , wherein the composition is a powder form.

12 . The method of claim 8 , wherein the composition is a dissolving film.

Assignments (1)
SECURITY INTEREST Recorded Apr 16, 2026
From: ORION INNOVATIONS, INC.; OXYSWITCH, LLC; OLSON, ROBERT; OLSON, DESHKA; PROVOST, WAYNE; MJ STEWART INVESTMENTS; MEDLITE ID, INC.
To: LIFE TECH, LLC
Reel/Frame 074391/0779 →